Difference between revisions of "Part:BBa K3053042"
LokshananR (Talk | contribs) |
LokshananR (Talk | contribs) |
||
| Line 20: | Line 20: | ||
To prove our methods, we first transformed <i>E.coli</i> cells with pBR322 which contains the <i>bla</i> gene. The growth in this plate is plentiful(image below).</p><br> | To prove our methods, we first transformed <i>E.coli</i> cells with pBR322 which contains the <i>bla</i> gene. The growth in this plate is plentiful(image below).</p><br> | ||
| − | < | + | <html> |
| − | + | <img src="https://2019.igem.org/wiki/images/1/10/T--VIT_Vellore--Result_A.jpeg" alt="Result_A" height="500" width="500"> | |
| + | </html> | ||
<br> | <br> | ||
| Line 29: | Line 30: | ||
<!--https://2019.igem.org/wiki/images/e/ef/T--VIT_Vellore--Result_C.jpeg--> | <!--https://2019.igem.org/wiki/images/e/ef/T--VIT_Vellore--Result_C.jpeg--> | ||
| + | |||
| + | <html> | ||
| + | <img src="https://2019.igem.org/wiki/images/e/ef/T--VIT_Vellore--Result_C.jpeg" alt="Result_A" height="500" width="500"> | ||
| + | </html> | ||
| + | <br> | ||
<!-- --> | <!-- --> | ||
Revision as of 21:38, 21 October 2019
Beta lactamase mRNA targeting sequence
This part is the culmination of all that we have done. This will produce the antisense mRNA which is designed to target the beta lactamase gene in pBR322 which confers antibiotic resistance against the antibiotic ampicillin.
Usage and Biology
This part works when there is the beta lactamase gene in the organism it is transformed with. Under this condition, the bla (shortened beta lactamase) mRNA is targeted by the mRNA produced by our part. This forms a double stranded mRNA covering the RBS region of the bla which causes the bla mRNA to degrade.
As a result of this, no beta lactamase is produced removing the bacteria's resistance to ampicillin. In the absence of a bla gene the sense part of our construct BBa_K3053069 (https://parts.igem.org/Part:BBa_K3053069) forms a self complementary stem loop and ensures its further degradation.
Methods and Validation
The working of our part can be proven in a very simple manner. Since our construct targets the bla mRNA which confers ampicillin resistance to the bacteria, its activity is bound to ideally resensitize the bacteria to the antibiotic. However practically, we expect it to significantly reduced the number of resistant bacteria.
To prove our methods, we first transformed E.coli cells with pBR322 which contains the bla gene. The growth in this plate is plentiful(image below).
The next step is to transform the E.coli cells with pSB1C3 which contains our construct. The plasmid contains a resistance gene for chloramphenicol which will act as our selection marker. Similar to the first transformation, ample growth is present in this plate as well. An image is shown below:
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 204
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]